Why FDA’s approval of genetic treatments are such an issue

On Thursday, an Food and drug administration advisory panel gave the eco-friendly light for any therapy that may enhance the vision of people that possess a rare genetic disorder known as Leber’s hereditary amaurosis (LCA). CBS News medical contributor Dr. Tara Narula weighs in.

Leave a Reply

Your email address will not be published. Required fields are marked *